Pancreatic cancer (Mia-PaCa2) cells exposed to 5 μM gemcitabine for 24 hours showed increased phosphorylation of CHEK1 at serine 317 and 345, which is indicative of CHEK1 activation [17] (Figure 5B). This evidence concerns the gene CHEK1 and pancreatic neoplasm.